Pioneer AI Foundry Commends Strategic Rebrand of Venture Partner StreaksAI PLC to TAO Alpha PLC and Its Alignment with the Decentralised AI Agent Economy 
The House of Life Unveils Award-Winning Luxury Handcrafted Tea Collection 
Colle AI Expands XRP Cryptocurrency Use to Power NFT Interoperability 
Atua AI Elevates Bitcoin Infrastructure to Enhance AI Workflow Security US Supreme Court denies Sandoz petition to review biosimilar Erelzi® (etanercept-szzs) case
Decision not to review Federal Circuit July 2020 ruling continues to prevent Sandoz launch of…
Novo Nordisk A/S – Share repurchase programme
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 17 May 2021 – On 7…
Report from LIDDS Annual General Meeting 2021
UPPSALA, SWEDEN – LIDDS Annual General Meeting (AGM) was held on May 17, 2021….
Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduced asthma attacks and improved lung function in children
Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduced asthma attacks…
Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip
TORONTO, May 17, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
Turning Point Therapeutics Names Kumar Srinivasan as Executive Vice President, Chief Business Officer
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
Leading Peer-Reviewed Ophthalmic Journal Publishes Study on ImprimisRx’s Proprietary Klarity-C® Drops
Multi-center Retrospective Study Demonstrates Statistically Significant Reduction in Signs and Symptoms of Dry Eye Disease…
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS17 MAY 2021 at 16.00 EEST …
Skye Bioscience’s THCVHS Demonstrates Superior Therapeutic Benefit Compared to Glaucoma Standard of Care, both as Combination and Single Agent, in Preclinical Study
THCVHS combined with netarsudil (Rhopressa®) achieves an average maximum intraocular pressure (IOP) reduction of…
SCYNEXIS Reports First Quarter 2021 Financial Results and Provides Corporate Update
Secured non-dilutive funding of approximately $35 million thus far in 2021, including licensing payments from…
Orchestra BioMed™ Announces Clinical Data Showing Significant and Sustained Reduction in Systolic Blood Pressure Out to Two Years with BackBeat Cardiac Neuromodulation Therapy™
Clinically meaningful and statistically significant reduction of 16.6 mmHg in systolic blood pressure out to…
Bioventus Senior Management to Present at Upcoming Investor Conferences
DURHAM, N.C., May 17, 2021 (GLOBE NEWSWIRE) — Senior management of Bioventus Inc. (Nasdaq: BVS)…
Vaccinex Reports First Quarter 2021 Financial Results and Provides Corporate Update
Initiated Phase 2 study of pepinemab in combination with KEYTRUDA® in advanced, recurrent or metastatic…
Alimera Sciences Appoints David Dyer, M.D. as Chief Retina Specialist
ATLANTA, May 17, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader…
Aeterna Zentaris Announces the Start of Preclinical Development of Macimorelin at The University of Queensland as a Potential New Treatment Option for Patients with Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s Disease)
– Aeterna Zentaris granted exclusive option to negotiate a license of any resulting intellectual property…
Akoya and ZEISS to Co-Market Innovative CODEX® Spatial Biology Workflow
The partnership brings together one of the world’s premier microscopy vendors and Akoya’s high-parameter CODEX®…
LIDDS Interim report January – March 2021
JANUARY – MARCH 2021 Net sales amounted to MSEK 0.6 (0.0) Operating expenses amounted to…
Gain Therapeutics to Participate in Upcoming Virtual Investor Conferences in May
BETHESDA, Md., May 17, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a…
Orion Animal Health’s Bonqat® (pregabalin) receives positive CVMP opinion
ORION CORPORATION PRESS RELEASE 17 MAY 2021 at 15.00 EEST Orion Animal Health’s Bonqat® (pregabalin)…
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2021
Cambridge, MA, May 17, 2021 – Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial…